keyword
https://read.qxmd.com/read/37921681/roflumilast-0-3-cream-a-phosphodiesterase-4-inhibitor-for-the-treatment-of-chronic-plaque-psoriasis
#41
RANDOMIZED CONTROLLED TRIAL
Samar E Nicolas, Michael D Bear, Abir O Kanaan, Oana Andreia Coman, Lorena Dima
BACKGROUND: Plaque psoriasis is a chronic dermatologic autoimmune disease that affects adults and children. Roflumilast 0.3% cream is currently the only topical phosphodiesterase 4 inhibitor indicated for the treatment of plaque psoriasis in patients 12 years or older. PHARMACODYNAMICS AND PHARMACOKINETICS: Roflumilast inhibits phosphodiesterase 4 inhibitor enzyme leading to the accumulation of cyclic adenosine monophosphate, which suppresses the inflammatory mediators interferon-γ and tumor necrosis factor-α...
November 2023: American Journal of Therapeutics
https://read.qxmd.com/read/37908893/estradiol-in-systemic-lupus-erythematosus
#42
JOURNAL ARTICLE
A M Constantin, C Baicus
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune polymorphous disease that primarily affects women of reproductive age. This gender disparity has suggested the importance of investigating the role of reproductive hormones in the pathogenesis of the disease. Estradiol, the most potent form of estrogen, plays a key role in shaping the immune system including the production of lymphocytes, the peripheral differentiation of regulatory T cells (T-regs), antibody production, and the complement and interferon systems, and has been studied in the pathogenesis of systemic lupus erythematosus (SLE)...
2023: Acta endocrinologica: the international journal of the Romanian Society of Endocrinology
https://read.qxmd.com/read/37894385/topical-and-intralesional-immunotherapy-for-the-management-of-skin-cancer-in-special-locations-lips-and-eyelids
#43
REVIEW
Cecilia Buján Bonino, Isabel Rodríguez-Blanco, Dolores Sánchez-Aguilar Rojas, Hugo A Vázquez Veiga, Ángeles Flórez
The use of topical and intralesional immunotherapy in the treatment of cutaneous malignant neoplasia in sensitive areas such as the lips and eyelids is discussed. Surgery may not be feasible or may result in deformities in these areas, making alternative treatment options necessary. A narrative literature review was conducted using MEDLINE (PubMed) as the main literature database, collecting available evidence of experiences with various topical and intralesional therapies in the aforementioned anatomical locations, ranging from case reports to clinical trials...
October 17, 2023: Cancers
https://read.qxmd.com/read/37874649/association-between-interferon-gamma-ifn-%C3%AE-gene-polymorphisms-and-tuberculosis-susceptibility-a-systematic-review-and-meta-analysis
#44
JOURNAL ARTICLE
Xu Hu, Xiaoying Lu
Interferon-gamma (IFN-γ) has been established to play a pivotal role in the pathogenesis of tuberculosis (TB). Existing evidence suggests a potential association between the genetic poly-morphisms of IFN-γ and the susceptibility to TB. However, this association remains a topic of controversy. To address this knowledge gap, a meta-analysis was conducted to provide more accurate results regarding their relationship. The pooled odds ratio along with its corresponding 95% confidence interval was calculated using four different gene models...
October 24, 2023: Nucleosides, Nucleotides & Nucleic Acids
https://read.qxmd.com/read/37842316/the-efficacy-of-topical-formulation-containing-ciplukan-physalis-angulata-linn-in-modulating-interleukin-17-and-interferon-gamma-expression-in-mice-mus-musculus-psoriasis-model
#45
JOURNAL ARTICLE
Oki Suwarsa, Hartati Purbo Dharmadji, Enny Rohmawaty, Shela Mareta, Hendra Gunawan, Reiva Farah Dwiyana, Pati Aji Achdiat, Endang Sutedja, Miranti Pangastuti
BACKGROUND: Interleukin 17 (IL-17) and interferon gamma (IFN-γ) play a role in the pathogenesis of psoriasis vulgaris (PV). Topical corticosteroids are still utilised as first-line therapy for mild to moderate PV. However, long-term use of corticosteroid is associated with various side effects. Physalis angulata Linn. (Ciplukan) possesses anti-inflammatory properties that could serve as a potential alternative topical therapy for PV. OBJECTIVE: To assess the efficacy of topical ciplukan as an anti-inflammatory agent targeting the expression of IL-17 and IFN-γ...
2023: Journal of Experimental Pharmacology
https://read.qxmd.com/read/37828737/prevalence-and-clinical-manifestations-of-cutaneous-findings-in-patients-with-adult-onset-immunodeficiency-due-to-anti-interferon-gamma-autoantibodies-an-eight-year-retrospective-study
#46
JOURNAL ARTICLE
Penvadee Pattanaprichakul, Charussri Leeyaphan, Nasikarn Angkasekwinai, Sumanas Bunyaratavej, Sansnee Senawong, Chudapa Sereeaphinan, Kanyalak Munprom
BACKGROUND: Cutaneous findings in adult-onset immunodeficiency due to anti-interferon gamma autoantibodies (anti-IFN-γ autoAbs) are common. Currently, data on this topic are scarce. METHODS: We retrospectively reviewed medical records of 202 skin episodes from 77 patients diagnosed with adult-onset immunodeficiency due to anti-IFN-γ autoAbs. The exclusion of drug eruptions left 180 episodes from 74 patients for further analysis. RESULTS: Reactive dermatosis was diagnosed in 66...
October 12, 2023: International Journal of Dermatology
https://read.qxmd.com/read/37779396/cladribine-efficacy-in-a-patient-with-hairy-cell-leukemia-and-severe-renal-insufficiency
#47
Alessandro Gozzetti, Francesca Bacchiarri, Donatella Raspadori, Anna Sicuranza, Vincenzo Sammartano, Monica Bocchia
BACKGROUND: Hairy cell leukemia commonly presents with pancytopenia, indolent course, and predisposition as infectious complications. Current first-line therapeutic options are purine analogues, particularly cladribine, with a high percentage of complete responses and durable remissions. However, their use is poorly investigated in patients affected by severe chronic renal insufficiency. CASE PRESENTATION: Here, we describe a case of HCL in a 68-year-old man affected by multiple comorbidities, including severe chronic renal failure...
September 28, 2023: Reviews on Recent Clinical Trials
https://read.qxmd.com/read/37761934/modulation-of-skin-cancer-by-the-stimulator-of-interferon-genes
#48
REVIEW
Max Oscherwitz, Victoria Jiminez, Hanna Terhaar, Nabiha Yusuf
Morbidity and mortality from skin cancer continue to rise domestically and globally, and melanoma and non-melanoma skin cancers are a topic of interest in the dermatology and oncology communities. In this review, we summarize the stimulator of interferon genes (STING) pathway, its specific role in the pathogenesis of DNA damage and skin cancer, and STING-specific therapies that may fight both melanoma and non-melanoma skin (NMSC) cancers. Furthermore, we discuss specific portions of the STING pathway that may be used in addition to previously used therapies to provide a synergistic effect in future oncology treatments and discuss the limitations of current STING-based therapies...
September 13, 2023: Genes
https://read.qxmd.com/read/37760438/topical-and-intralesional-immunotherapy-for-melanoma-in-situ-a-review
#49
REVIEW
Sandra Martínez-Fernández, Beatriz González-Sixto, Martina Espasandín-Arias, Diego Soto-García, Ángeles Flórez
The incidence of in situ melanoma (MIS) has increased over the last decades. The mainstay of treatment for MIS, including lentigo maligna (LM), is complete surgical excision with clear margins (0.5 to 1.0 cm). Nevertheless, MIS lesions often affect elderly patients with comorbidities and involve large lesions in cosmetically sensitive areas, which means surgery is not always appropriate. Non-surgical treatments have a role in these cases, and include radiotherapy, cryosurgery, immunotherapy, laser therapy, and other topical medications...
September 8, 2023: Cancers
https://read.qxmd.com/read/37748784/preventive-care-recommendations-to-promote-health-equity
#50
JOURNAL ARTICLE
Nav Persaud, Areesha Sabir, Hannah Woods, Ambreen Sayani, Arnav Agarwal, Muna Chowdhury, Kathleen de Leon-Demare, Somtochukwu Ibezi, Saadia Hameed Jan, Alan Katz, Frantz-Daniel LaFortune, Melanie Lewis, Trudy McFarlane, Anjali Oberai, Yinka Oladele, Onyema Onyekwelu, Lisa Peters, Patrick Wong, Aisha Lofters
BACKGROUND: Avoidable disparities in health outcomes persist in Canada despite substantial investments in a publicly funded health care system that includes preventive services. Our objective was to provide preventive care recommendations that promote health equity by prioritizing effective interventions for people experiencing disadvantages. METHODS: The guideline was developed by a primary care provider-patient panel, with input from a patient-partner panel with diverse lived experiences...
September 25, 2023: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/37739337/type-i-interferon-derived-from-ly6chi-monocytes-suppresses-type-2-inflammation-in-murine-model-of-atopic-dermatitis
#51
JOURNAL ARTICLE
Fumi Miyagawa, Keiko Ozato, Yutaka Tagaya, Hideo Asada
The roles of innate immune cells including eosinophils, basophils and group 2 innate lymphoid cells in atopic dermatitis (AD) have been well documented, whereas that of monocytes, another component of the innate immunity, remains rather poorly understood and thus the topic of this study. Additionally, cytokines and cellular pathways needed for the resolution of type 2 inflammation in AD need further investigation. Using a murine AD model, we report here that 1) Ly6Chi monocytes were rapidly recruited to the AD lesion by a CCR2-dependent manner, blockade of which exacerbated AD...
September 20, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37716650/phototherapy-restores-deficient-type-i-interferon-production-and-enhances-antitumor-responses-in-mycosis-fungoides
#52
JOURNAL ARTICLE
Zizi Yu, Pablo Vieyra-Garcia, Theresa Benezeder, Jack D Crouch, Ira R Kim, John T O'Malley, Phillip M Devlin, Ahmed Gehad, Qian Zhan, Johann E Gudjonsson, Mrinal K Sarkar, J Michelle Kahlenberg, Nega Gerard, Jessica E Teague, Thomas S Kupper, Nicole R LeBoeuf, Cecilia Larocca, Marianne Tawa, Bohdan Pomahac, Simon G Talbot, Dennis P Orgill, Peter Wolf, Rachael A Clark
Transcriptional profiling demonstrated markedly reduced type I interferon gene expression in untreated mycosis fungoides skin lesions compared to healthy skin. Type I interferon expression in MF correlated with APC-associated IRF5 before PUVA and epithelial ULBP2 after therapy, suggesting an enhancement of epithelial type I IFN. Immunostains confirmed reduced baseline type I interferon production in MF and increased levels post-PUVA in responding patients. Effective tumor clearance was associated with increased type I interferon expression, enhanced recruitment of CD8+ T cells into skin lesions and expression of genes associated with antigen specific T cell activation...
September 14, 2023: Journal of Investigative Dermatology
https://read.qxmd.com/read/37686078/anti-inflammatory-effects-of-spirodela-polyrhiza-l-s-chleid-extract-on-contact-dermatitis-in-mice-its-active-compounds-and-molecular-targets
#53
JOURNAL ARTICLE
Kukhwa Kim, Daniel Lee, Han-Young Kim, Soyeon Kim, Ji-Hyo Lyu, Sujung Park, Young-Chul Park, Hyungwoo Kim
Spirodela polyrhiza (L.) SCHLEID . has been used to treat epidemic fever, dysuria, and various skin ailments, such as measles eruptions, eczema, and pruritus, in China, Japan, and Korea. In this study, the active compounds in S. polyrhiza and their target genes were identified by network-based analysis. Moreover, the study evaluated the effects of a 70% ethanolic extract of S. polyrhiza (EESP) on skin lesions, histopathological changes, inflammatory cytokines, and chemokines in mice with contact dermatitis (CD) induced by 1-fluoro-2,4-dinitrobenzene (DNFB), and examined the inhibitory effects of EESP on mitogen-activated protein kinase (MAPK) signalling pathways...
August 26, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37672841/disease-modifying-therapy-and-pregnancy-outcomes-in-multiple-sclerosis-a-systematic-review-and-meta-analysis
#54
REVIEW
Erum Khan, Yusuf Kagzi, Mahmoud Elkhooly, Swapnil Surpur, Sijin Wen, Kanika Sharma, Shitiz Sriwastava
OBJECTIVES: To report pregnancy outcomes among multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs). METHODS: We performed a retrospective chart review of articles published from June 1996 to May 2023. Additional information was acquired from the drug registries of individual pharmaceutical companies. A comparison was also made with pregnancy data of the general population using the World Health Organization database. Summary analysis was achieved using R statistical software (v3...
October 15, 2023: Journal of Neuroimmunology
https://read.qxmd.com/read/37663384/a-promising-impact-of-oral-administration-of-noscapine-against-imiquimod-induced-psoriasis-like-skin-lesions
#55
JOURNAL ARTICLE
Fahimeh Nourbakhsh, Seyed Hadi Mousavi, Pouria Rahmanian-Devin, Vafa Baradaran Rahimi, Hassan Rakhshandeh, Vahid Reza Askari
OBJECTIVE: Psoriasis is a chronic inflammatory autoimmune disease. The effectiveness of noscapine has been employed as a helpful treatment for various disorders and subjected to recent theoretical breakthroughs. MATERIALS AND METHODS: Psoriasis-like lesions were induced by topical application of 5% imiquimod (IMQ) (10 mg/cm2 of skin) in male Balb/c mice and then medicated with a single oral dose of methotrexate (MET) as a positive control or daily oral treatment of noscapine (5, 15 and 45 mg/kg)...
2023: Avicenna Journal of Phytomedicine
https://read.qxmd.com/read/37661787/pharmacokinetics-tolerability-and-safety-of-glecaprevir-pibrentasvir-co-formulated-bilayer-tablet-following-repeated-administration-in-healthy-chinese-adults
#56
JOURNAL ARTICLE
Hari V Kalluri, Rajneet K Oberoi, Qian Chen, Qi Jiang, Armen Asatryan, Negar N Alami, Chen Yu, Wei Liu
Glecaprevir (GLE)/pibrentasvir (PIB) is an all-oral, interferon- and ribavirin-free, pan-genotypic fixed-dose combination regimen approved for the treatment of all major genotypes of hepatitis C virus (HCV) infection in many countries worldwide. To support clinical development in China, an open-label, single-center phase 1 study was conducted to evaluate the pharmacokinetics, safety, and tolerability of GLE/PIB in healthy Chinese adults in Mainland China. Eighteen participants received 3 tablets of coformulated GLE/PIB 100/40 mg once daily (QD) for 7 days...
September 4, 2023: Clinical Pharmacology in Drug Development
https://read.qxmd.com/read/37644513/facilitators-and-barriers-to-latent-tuberculosis-infection-treatment-among-primary-healthcare-workers-in-malaysia-a-qualitative-study
#57
JOURNAL ARTICLE
Siti Nur Farhana H, Anusha Manoharan, Wen Ming Koh, Manimaran K, Ee Ming Khoo
BACKGROUND: Healthcare workers (HCWs) have an increased risk of active and latent tuberculosis infection (LTBI) compared to the general population. Despite existing guidelines on the prevention and management of LTBI, little is known about why HCWs who tested positive for LTBI refuse treatment. This qualitative study sought to explore the facilitators and barriers to LBTI treatment uptake among primary HCWs in Malaysia. METHODS: This qualitative study used a phenomenological research design and was conducted from July 2019 to January 2021...
August 29, 2023: BMC Health Services Research
https://read.qxmd.com/read/37643461/adjuvant-topical-interferon-alpha-2b-for-the-treatment-of-monkeypox-ocular-manifestations
#58
JOURNAL ARTICLE
José Y Arteaga-Rivera, Itamar Vigderovich-Cielak, Arturo Ramirez-Miranda, Andrea González, Emmanuel Frías-Jimenez, Ivonne E Arriaga-Guzman, Juan G Sierra Madero, Alejandro Navas, Enrique O Graue-Hernandez
PURPOSE: The aim of this study was to report a case of ocular Mpox that responded favorably to treatment with topical interferon and oral doxycycline. METHODS: This is a case report of a previously healthy 24-year-old woman who developed a pustular rash, headache, fever, arthralgia, sore throat, and asthenia 3 weeks before attending to our clinic. Her main complaint at the moment of the visit was pain, photophobia, foreign body sensation, blurred vision, red eye, and discharge on the left eye...
August 23, 2023: Cornea
https://read.qxmd.com/read/37634490/clinical-differences-between-posner-schlossman-syndrome-patients-with-intermittent-intraocular-pressure-elevation-and-glaucomatous-damage
#59
JOURNAL ARTICLE
Qian Wang, Wen Zeng, Weijuan Zeng, Yang Liu, Min Ke
INTRODUCTION: Although there is abundant evidence that Posner-Schlossman syndrome (PSS) can lead to secondary glaucoma, data on the clinical differences between PSS patients with secondary glaucoma and those with intermittent intraocular pressure (IOP) elevation are sparse. METHODS: This retrospective observational study included 52 patients (52 eyes) diagnosed with PSS and admitted to Zhongnan Hospital of Wuhan University between January 2019 and February 2022...
August 25, 2023: Ophthalmic Research
https://read.qxmd.com/read/37615837/a-propensity-score-matched-study-on-the-changes-of-tb-status-and-tb-igra-values-in-patients-with-psoriasis-with-latent-tb-receiving-secukinumab
#60
JOURNAL ARTICLE
Yue Xiao, Wenyao Mi, Jinqiu Wang, Dingke Wen, Yiyi Wang, Yuanxia Gu, Dan Hao, Wei Yan, Xuerong Chen, Wei Li
INTRODUCTION: The utilization of biologics in patients with psoriasis with latent tuberculosis infection (LTBI) has garnered significant attention. Although the tuberculosis (TB) safety profile of second-generation biologics, including secukinumab, has been partially confirmed in both clinical trials and real-world studies, the necessity for prophylactic therapy in patients with LTBI prior to administering this class of biologics remains a topic of controversy. METHODS: This study enrolled 62 patients with psoriasis with LTBI who underwent secukinumab with routine TB reexamination...
August 24, 2023: Dermatology and Therapy
keyword
keyword
166663
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.